Enzar Forte Tablet contains a combination of Pancreatin (170 mg) and Sodium Tauroglycocholate (65 mg), formulated to aid digestive processes by enhancing enzymatic activity and bile salt function. Pancreatin is a mixture of digestive enzymes including amylase, lipase, and protease, which facilitate the breakdown of carbohydrates, fats, and proteins, respectively, thereby improving nutrient absorption in patients with pancreatic insufficiency or related digestive disorders. Sodium Tauroglycocholate acts as a bile salt analogue, promoting emulsification and absorption of dietary fats and fat-soluble vitamins, which complements the enzymatic activity of pancreatin. Enzar Forte is indicated for conditions such as chronic pancreatitis, cystic fibrosis, post-pancreatectomy, and other disorders characterized by exocrine pancreatic insufficiency. The combination enhances overall digestive efficiency, reduces symptoms like steatorrhea, bloating, and malnutrition, and supports optimal gastrointestinal function. It is recommended to be taken orally with meals to maximize therapeutic effects. Caution is advised in patients with hypersensitivity to any component, and dosage adjustments may be necessary based on clinical response. Enzar Forte should be used under medical supervision to ensure appropriate management of digestive enzyme deficiency and related conditions.